BlackRock Investment Management, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 96 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$891,000
-35.2%
374,383
-0.2%
0.00%
-50.0%
Q3 2016$1,376,000
+78.0%
375,016
+8.2%
0.00%
+100.0%
Q2 2016$773,000
+17.5%
346,722
+9.5%
0.00%0.0%
Q1 2016$658,000
-32.2%
316,511
-1.1%
0.00%0.0%
Q4 2015$970,000
+23.9%
320,112
+1.0%
0.00%0.0%
Q3 2015$783,000
-24.6%
316,909
-2.1%
0.00%0.0%
Q2 2015$1,039,000
+0.8%
323,610
+12.1%
0.00%0.0%
Q1 2015$1,031,000
+56.4%
288,736
-0.5%
0.00%0.0%
Q4 2014$659,000
-5.3%
290,262
-19.1%
0.00%0.0%
Q3 2014$696,000
-47.0%
358,627
-0.8%
0.00%
-50.0%
Q2 2014$1,312,000
+13.8%
361,558
+21.7%
0.00%0.0%
Q1 2014$1,153,000
+35.6%
297,076
-0.4%
0.00%
+100.0%
Q4 2013$850,000
-21.9%
298,344
-1.9%
0.00%
-50.0%
Q3 2013$1,089,000
+7.9%
304,203
+0.7%
0.00%0.0%
Q2 2013$1,009,000301,9950.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,020,719$3,746,0002.58%
Boxer Capital, LLC 1,351,137$4,959,0002.22%
Palo Alto Investors LP 5,186,088$19,033,0001.11%
DAFNA Capital Management LLC 340,000$1,248,0000.87%
SENZAR ASSET MANAGEMENT, LLC 907,203$3,329,435,0000.86%
Rhenman & Partners Asset Management AB 1,400,000$5,138,000,0000.82%
NEA Management Company, LLC 3,243,150$11,902,0000.53%
Cormorant Asset Management, LP 1,155,600$4,241,0000.47%
Ghost Tree Capital, LLC 700,000$2,569,0000.42%
Rock Springs Capital Management LP 1,810,000$6,643,0000.42%
View complete list of RIGEL PHARMACEUTICALS INC shareholders